Patents Assigned to Zindaclin Limited
  • Dermatalogical formulations
    Patent number: 8268790
    Abstract: Aqueous preparations of substantially equimolor amounts of a zinc salt and clindamycin phosphate form a polymer useful in the topical treatment of acne and rosacea, with very low systemic levels of clindamycin.
    Type: Grant
    Filed: October 6, 2009
    Date of Patent: September 18, 2012
    Assignee: Zindaclin Limited
    Inventors: Emma Louise McDonagh, Rebecca Louise Kanis